Anti-Cancer Agents in Medicinal Chemistry
Title:PREFACE
Volume: 17 Issue: 1
Author(s): Michelle Prudhomme
Affiliation:
Export Options
About this article
Cite this article as:
Prudhomme Michelle, PREFACE, Anti-Cancer Agents in Medicinal Chemistry 2017; 17 (1) . https://dx.doi.org/10.2174/187152061701161207130106
DOI https://dx.doi.org/10.2174/187152061701161207130106 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
25
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Blockade of Furin Activity and Furin-Induced Tumor Cells Malignant Phenotypes By The Chemically Synthesized Human Furin Prodomain
Current Medicinal Chemistry Autoimmunity and Frontotemporal Dementia
Current Alzheimer Research A Novel Lily-of-the-Valley Fragrance Contrast Agent for Magnetic Resonance and Fluorescence Imaging of Prostate Cancer Cells
Current Pharmaceutical Biotechnology Repositioning the Old Fungicide Ciclopirox for New Medical Uses
Current Pharmaceutical Design Herpesvirus Saimiri-Based Gene Delivery Vectors
Current Gene Therapy NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Peptides for Tumour Therapy and Diagnosis: Current Status and Future Directions
Current Medicinal Chemistry Recent Advances in Liposomal Drug Delivery: A Review
Pharmaceutical Nanotechnology Metabotropic Glutamate Receptors in Central Nervous System Diseases
Current Drug Targets Tracking the Mesenchymal Stem Cell Fate After Transplantation Into the Infarcted Myocardium
Current Stem Cell Research & Therapy Subject Index To Volume 7
Current Drug Targets TGF-β1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis
Current Pharmaceutical Design Non-viral Gene Delivery and Therapeutics Targeting to Brain
Current Nanoscience Annexins as Neuroprotective Agents in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Fibroblast Activation Protein in Remodeling Tissues
Current Molecular Medicine Telomeric G-Quadruplex Architecture and Interactions with Potential Drugs
Current Pharmaceutical Design The Interest of Folic Acid in Targeted Photodynamic Therapy
Current Medicinal Chemistry Irinotecan for Treatment of Childhood Cancers: A Promising Therapeutic Partner
Current Cancer Therapy Reviews TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy
Current Molecular Medicine Genetic Surgery - A Right Strategy to Attack Cancer
Current Gene Therapy